Acumen Pharmaceuticals (ABOS) Treasury Shares (2023 - 2026)

Acumen Pharmaceuticals' Treasury Shares history runs 4 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 49.49% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (up 49.49% YoY), while the FY2025 annual figure was $1.9 million, up 40.86% from the prior year.
• Treasury Shares came in at $2.8 million for Q1 2026 at Acumen Pharmaceuticals, up from $1.9 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.8 million in Q1 2026 to a low of $328500.0 in Q1 2023.
• A 4-year average of $1.3 million and a median of $1.4 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares soared 333.38% in 2024 and gained 29.75% in 2025, its largest moves.
• Acumen Pharmaceuticals' Treasury Shares stood at $328500.0 in 2023, then jumped by 312.34% to $1.4 million in 2024, then jumped by 40.86% to $1.9 million in 2025, then soared by 44.72% to $2.8 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $2.8 million, $1.9 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison